Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.4
Consolidated Balance Sheets - USD ($)
Nov. 30, 2020
Nov. 30, 2019
Current Assets    
Cash and cash equivalents $ 10,361,125 $ 6,541,037
Marketable securities 88,476 904,053
Accounts receivable (net of allowance for doubtful accounts of $2,781,668 and $2,584,091, respectively) 6,322,960 6,097,331
Prepaid expenses 611,627 500,260
Inventory, current portion 927,318 1,084,533
Other current assets 244,696 260,397
Total current assets 18,556,202 15,387,611
Property and Equipment-net 1,640,774 1,846,467
Other Assets    
Intangible assets, net 1,181,588 1,249,254
Inventory, net of current portion 11,064,034 12,646,000
Goodwill 1,941,411 1,941,411
Deferred tax assets 10,363,967 9,079,994
Operating lease right-of-use asset 299,089  
Deposits and other assets, net 495,029 427,423
Total other assets 26,003,118 25,652,082
Total assets 46,200,094 42,886,160
Current Liabilities    
Accounts payable 957,390 1,369,111
Accrued expenses 2,898,211 2,085,180
Current portion of note payable 3,100,000 3,100,000
Current portion of operating lease liability 275,570  
Deferred revenue 9,183,450 8,875,138
Total current liabilities 16,414,621 15,429,429
Other Liabilities    
Deferred revenue, net of current portion 27,200,910 23,633,373
Contingent consideration 1,509,852 3,495,057
Note payable, net of current portion and debt issuance costs 2,841,214 5,856,152
Operating lease long-term liability 23,632  
Long-term liability - revenue sharing agreements 875,000 1,425,000
Total other liabilities 32,450,608 34,409,582
Total liabilities 48,865,229 49,839,011
Commitments and contingencies (Note 12) 0 0
Stockholders' Deficit    
Preferred stock 0 0
Common stock ($.01 par value, 20,000,000 authorized; 13,633,638 issued and 7,545,613 outstanding as of November 30, 2020 and 13,598,909 issued and 7,510,884 outstanding as of November 30, 2019) 136,336 135,989
Additional paid-in capital 36,581,600 35,918,827
Treasury stock, at cost (20,563,357) (20,563,357)
Accumulated deficit (18,819,714) (22,444,310)
Total stockholders' deficit (2,665,135) (6,952,851)
Total liabilities and stockholders' deficit 46,200,094 42,886,160
Series A Junior Participating Preferred Stock [Member]    
Stockholders' Deficit    
Preferred stock 0 0
Tianhe Stem Cell Biotechnologies Inc [Member]    
Other Assets    
Investment - Tianhe stock 308,000 $ 308,000
Patent Option Agreement [Member]    
Other Assets    
Investment - Tianhe stock $ 350,000